Prof. Mesut ŞEKER

Publication Network

Published journal articles indexed by SCI, SSCI, and AHCI

Local interventions for colorectal cancer metastases to liver and lung

ŞİMŞEK M., Besiroglu M., AKÇAKAYA A., Topcu A., Yasin A. I., Isleyen Z. S., et al.

Irish Journal of Medical Science , 2023 (SCI-Expanded) Sustainable Development

The efficacy of BNT162b2 (Pfizer-BioNTech) and CoronaVac vaccines in patients with cancer

ŞİMŞEK M., Yasin A., BEŞİROĞLU M., TOPÇU A., SUCUOĞLU İŞLEYEN Z., ŞEKER M., et al.

JOURNAL OF MEDICAL VIROLOGY , vol.94, no.9, pp.4138-4143, 2022 (SCI-Expanded) Sustainable Development

Real-life analysis of pathologic complete response with neoadjuvant trastuzumab plus taxane with or without pertuzumab therapy in HER2 positive locally-advanced breast cancer (HER2PATH Study).

Bilici A., Olmez O. F., Sezer A., Oksuzoglu B., Kaplan M. A., Karadurmus N., et al.

JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.16, 2022 (SCI-Expanded) Sustainable Development

Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study

YASİN A. İ., Aydin S. G., SÜMBÜL B., KORAL L., ŞİMŞEK M., Geredeli C., et al.

FUTURE ONCOLOGY , vol.18, pp.1235-1244, 2022 (SCI-Expanded) Sustainable Development

A case report of fulminant hepatitis due to ribociclib with confirmed by liver biopsy in breast cancer

TOPÇU A., YASİN A. İ., SHBAIR A. T., BEŞİROĞLU M., ŞİMŞEK M., SUCUOĞLU İŞLEYEN Z., et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.28, no.1, pp.242-246, 2022 (SCI-Expanded) Sustainable Development

Real-life analysis of treatment approaches and the role of inflammatory markers on survival in patients with advanced biliary tract cancer

Goktas Aydin S., Cakan Demirel B., Bilici A., TOPÇU A., Aykan M. B., KAHRAMAN S., et al.

Current Medical Research and Opinion , vol.38, no.10, pp.1751-1758, 2022 (SCI-Expanded) Sustainable Development

Primitive Neuroectodermal Tumor of the Testis

DEMİR T., ALİYEV A., ŞEKER M., ERSÖZ C., ÇOBAN G., TÜRK H. M.

JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN , vol.31, no.11, pp.1362-1365, 2021 (SCI-Expanded)

Platelet to lymphocyte ratio is associated with tumor localization and outcomes in metastatic colorectal cancer

Acikgoz O., Cakan B., DEMİR T., Bilici A., Oven B. B., Hamdard J., et al.

MEDICINE , vol.100, no.44, 2021 (SCI-Expanded) Sustainable Development

Clinicopathological features of gastroenteropancreatic neuroendocrine neoplasms: a retrospective single-center experience

ŞEKERCİ A., TÜRK H. M., DEMİR T., ŞEKER M., AKÇAKAYA A., ARICI D. S.

NEUROENDOCRINOLOGY , vol.111, pp.20, 2021 (SCI-Expanded)

Determine the impact of hybrid capture-based comprehensive genomic profiling (CGP) on the treatment strategies in patients with solid tumors: A national, multicenter, retrospective study.

Disel U., Kose F., Bilici A., Ozguroglu M., Saglam S., Seker M., et al.

JOURNAL OF CLINICAL ONCOLOGY , vol.38, no.15, 2020 (SCI-Expanded)

Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer.

Turk H. M., Aliyev A., Celik R., Seker M., Coban E., Demir T., et al.

Current problems in cancer , vol.44, no.1, pp.100497, 2020 (SCI-Expanded) Sustainable Development

Correlationof Caveolin-1 Expression with Prognosis in Patients with Gastric Cancer after Gastrectomy.

ŞEKER M., AYDIN D., BİLİCİ A., YAVUZER D., GEÇER M., ÖZÇELİK M., et al.

Oncology Research , 2020 (SCI-Expanded) Sustainable Development

Prognostic Significance of Metastatic Lymph Node Ratio in Patients with pN3 Gastric Cancer Who Underwent Curative Gastrectomy.

Bilici A., Selcukbiricik F., Seker M., Oven B., Olmez O., Yildiz O., et al.

Oncology research and treatment , vol.42, pp.209-216, 2019 (SCI-Expanded) Sustainable Development

Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients

Seker M., ISEN H. C., Cevirme N., Aydin S., Bilici A., Bulut H., et al.

ONCOLOGY RESEARCH AND TREATMENT , vol.41, no.9, pp.545-549, 2018 (SCI-Expanded) Sustainable Development

Correlation of Caveolin-1 Expression with Prognosis in Patients with Gastric Cancer after Gastrectomy

Seker M., AYDIN D., Bilici A., YAVUZER D., OZGUN M. G., OZCELIK M., et al.

ONCOLOGY RESEARCH AND TREATMENT , vol.40, no.4, pp.185-190, 2017 (SCI-Expanded) Sustainable Development

Comparison of efficacy and safety of three different chemotherapy regimens delivered with concomitant radiotherapy in inoperable stage III non-small cell lung cancer patients

OZCELIK M., KORKMAZ T., ODABAS H., GEMICI C., ERCELEP O., YUKSEL S., et al.

TUMOR BIOLOGY , vol.37, no.7, pp.8901-8907, 2016 (SCI-Expanded) Sustainable Development

Evaluation of prognostic factors in localized high-grade undifferentiated pleomorphic sarcoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology

OZCELIK M., ŞEKER M., ERASLAN E., Koca S., YAZILITAS D., ERCELEP O., et al.

Tumor Biology , vol.37, no.4, pp.5231-5237, 2016 (SCI-Expanded)

Pretreatment PET/ct standardized uptake values play a role in predicting response to treatment and survival in patients with small cell lung cancer

DINC N. S., AYDLN K., ODABAS H., ERCELEP O., Tufan G., ŞEKER M., et al.

Oncology Research and Treatment , vol.39, no.3, pp.130-134, 2016 (SCI-Expanded) Sustainable Development

The changing of serum vitamin B12 and homocysteine levels after gastrectomy in patients with gastric cancer: do they associate with clinicopathological factors?

BILICI A., SONKAYA A., ERCAN S., USTAALIOĞLU B., Seker M., ALIUSTAOGLU M., et al.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine , vol.36, pp.823-8, 2015 (SCI-Expanded) Sustainable Development

Treatment modalities in primary gastric lymphoma: The effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical Oncology

Mehmet K., SENER C., UYETURK U., Seker M., Tastekin D., Tonyali O., et al.

Wspolczesna Onkologia , vol.18, no.4, pp.273-278, 2014 (SCI-Expanded)

Clinical and pathologic features of patients with rare ovarian tumors: multi-center review of 167 patients by the anatolian society of medical oncology.

BILICI A., INANC M., ULAS A., AKMAN T., Seker M., BABACAN N., et al.

Asian Pacific journal of cancer prevention : APJCP , vol.14, pp.6493-9, 2014 (SCI-Expanded)

Important factors affecting adjuvant treatment decision in stage IA breast cancer patients in Turkey

OVEN USTAALIOGLU B. B., Bilici A., YILMAZ B. E., ALIUSTAOGLU M., Seker M., VARDAR F., et al.

Breast Care , vol.9, no.2, pp.123-127, 2014 (SCI-Expanded)

Efficacy of sunitinib in Turkish patients with gastrointestinal stromal tumors; retrospective multicenter experience.

KEFELI U., BUYUBERBER S., AKYOL M., YILDIZ R., KAPLAN M., CILTAS A., et al.

Hepato-gastroenterology , vol.60, pp.647-52, 2013 (SCI-Expanded)

The prognostic importance of changing serum M30 and M65 values after chemotherapy in patients with advanced-stage non-small-cell lung cancer.

USTAALIOĞLU B., BILICI A., ERCAN S., Seker M., ORCUN A., GUMUS M.

Medical oncology (Northwood, London, England) , vol.30, pp.551, 2013 (SCI-Expanded) Sustainable Development

Prognostic factors in gastrointestinal stromal tumors: multicenter experience of 333 cases from Turkey.

Seker M., SEVINC A., YILDIZ R., CIHAN S., KAPLAN M., GOKDURNALI A., et al.

Hepato-gastroenterology , vol.60, pp.768-75, 2013 (SCI-Expanded)

Childhood, adolescents, and young adults (≤25 y) colorectal cancer: study of Anatolian Society of Medical Oncology.

KAPLAN M., ISIKDOGAN A., GUMUS M., ARSLAN U., GEREDELI C., OZDEMIR N., et al.

Journal of pediatric hematology/oncology , vol.35, pp.83-9, 2013 (SCI-Expanded) Sustainable Development

XELIRI plus bevacizumab compared with FOLFIRI plus bevacizumab as first-line setting in patients with metastatic colorectal cancer: experiences at two-institutions.

UYGUN K., BILICI A., KAYA S., Oven U., YILDIZ R., TEMIZ S., et al.

Asian Pacific journal of cancer prevention : APJCP , vol.14, pp.2283-8, 2013 (SCI-Expanded)

The prognostic significance of the increase in the serum M30 and M65 values after chemotherapy and relationship between these values and clinicopathological factors in patients with advanced gastric cancer.

BILICI A., USTAALIOĞLU B., ERCAN S., Seker M., YILMAZ B., ORCUN A., et al.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine , vol.33, pp.2201-8, 2012 (SCI-Expanded) Sustainable Development

Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patients.

ELKIRAN E., KAPLAN M., SEVINC A., AKSOY S., DEMIRCI U., Seker M., et al.

Medical oncology (Northwood, London, England) , vol.29, pp.3147-54, 2012 (SCI-Expanded)

The importance of multifocal/multicentric tumor on the disease-free survival of breast cancer patients: single center experience.

USTAALIOGLU B., BILICI A., KEFELI U., Şeker M., ONCEL M., GEZEN C., et al.

American journal of clinical oncology , vol.35, pp.580-6, 2012 (SCI-Expanded) Sustainable Development

The prevalence and significance of autoantibodies in patients with non-Hodgkin's lymphoma: are they correlated with clinicopathological features?

BILICI A., YAPICI H., ERCAN S., Seker M., USTAALIOĞLU B., SALMAN T., et al.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology , vol.17, pp.502-7, 2012 (SCI-Expanded)

Prognostic significance of high phosphatase of regenerating liver-3 expression in patients with gastric cancer who underwent curative gastrectomy.

BILICI A., USTAALIOĞLU B., YAVUZER D., Seker M., MAYADAGLI A., GUMUS M.

Digestive diseases and sciences , vol.57, pp.1568-75, 2012 (SCI-Expanded) Sustainable Development

Serum M30 and M65 values in patients with advanced stage non-small-cell lung cancer compared with controls.

Oven U., BILICI A., ERCAN S., ORCUN A., Seker M., OZKAN A., et al.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico , vol.14, pp.356-61, 2012 (SCI-Expanded) Sustainable Development

Is subdivision of pT2 tumors superior to lymph node metastasis for predicting survival of patients with gastric cancer? Review of 224 patients from four centers.

BILICI A., DANE F., Seker M., USTAALIOĞLU B., ALIUSTAOGLU M., TEMIZ S., et al.

Digestive diseases and sciences , vol.56, pp.3226-34, 2011 (SCI-Expanded) Sustainable Development

Tissue and Serum Adiponectin Levels in Patients with Gastric Cancer: Are there any Correlations between Adiponectin Levels and Histopathological Variables?

ŞEKER M., Bilici A., Güler D. Ö., Ustaalioglu B. B., Gozu H., Erkal F. Y., et al.

HEPATO-GASTROENTEROLOGY , vol.58, no.110, pp.1841-1846, 2011 (SCI-Expanded) Sustainable Development

Prognostic factors in elderly patients with non-small cell lung cancer: a two-center experience.

KEFELI U., KAYA S., USTAALIOGLU B., BILICI A., KEFELI A., YILDIRIM M. Ş., et al.

Medical oncology (Northwood, London, England) , vol.28, pp.661-6, 2011 (SCI-Expanded) Sustainable Development

Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?

BILICI A., USTAALIOĞLU B., ERCAN S., ORCUN A., Seker M., SALEPCI T., et al.

Cancer chemotherapy and pharmacology , vol.68, pp.309-16, 2011 (SCI-Expanded) Sustainable Development

Clinicopathologic features of the nine patients with primary diffuse large B cell lymphoma of the breast

ŞEKER M., Bilici A., Ustaalioglu B. Ö., Yılmaz B., Öztürk B., Ünal A., et al.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS , vol.284, no.2, pp.405-409, 2011 (SCI-Expanded) Sustainable Development

F-18 FDG PET/CT imaging and bronchoscopic image of tracheal recurrence in patient with non-small-cell lung cancer.

Oven U., KEFELI U., BILICI A., USTAALIOGLU R., Seker M., CINARAL F., et al.

Clinical nuclear medicine , vol.36, pp.367-9, 2011 (SCI-Expanded) Sustainable Development

Co-existence of gastrointestinal stromal tumors with other primary neoplasms.

SEVINC A., Seker M., BILICI A., OZDEMIR N., YILDIZ R., USTAALIOGLU B., et al.

Hepato-gastroenterology , vol.58, pp.824-30, 2011 (SCI-Expanded)

Pulmonary BALT lymphoma successfully treated with eight cycles weekly rituximab: Report of first case and F-18 FDG PET/CT images

Bilici A., Seker M., USTAALIOGLU B. B. O., CANPOLAT N., Salepci T., Gümüş M.

Journal of Korean Medical Science , vol.26, no.4, pp.574-576, 2011 (SCI-Expanded)

A retrospective analysis of women's chances to become pregnant after completion of chemotherapy: a single center experience

USTAALIOGLU B. B. O., BILICI A., KEFELI U., Seker M., SALEPCI T., UNAL O., et al.

JOURNAL OF BUON , vol.16, no.2, pp.349-352, 2011 (SCI-Expanded) Sustainable Development

Is there any correlation among adiponectin levels in serum, tumor tissue and normal tissue of the same patients wih breast cancer?

SONMEZ B., Seker M., BILICI A., Yavuz E., Oven U., GUMUS M., et al.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology , vol.16, pp.227-32, 2011 (SCI-Expanded) Sustainable Development

The role of PET-CT in the differential diagnosis of thymic mass after treatment of patients with lymphoma.

USTAALIOĞLU B., Seker M., BILICI A., CANPOLAT N., YILDIRIM E. Ö., KEFELI U., et al.

Medical oncology (Northwood, London, England) , vol.28, pp.258-64, 2011 (SCI-Expanded)

A case of metastatic breast cancer successfully treated with lapatinib plus capecitabine therapy.

KEFELI U., BILICI A., USTAALIOĞLU B., KEFELI A., YILDIRIM M. Ş., Seker M., et al.

Archives of gynecology and obstetrics , vol.283, pp.405-7, 2011 (SCI-Expanded) Sustainable Development

Primary breast mantle cell lymphoma with atypical relapse patterns.

DANE F., Seker M., Fulden Y., GUNDUZ F., PEKER O., BASARAN G., et al.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology , vol.16, pp.181-2, 2011 (SCI-Expanded)

The role of ¹⁸F-FDG PET/CT in the assessment of suspected recurrent gastric cancer after initial surgical resection: can the results of FDG PET/CT influence patients' treatment decision making?

BILICI A., USTAALIOĞLU B., Seker M., KEFELI U., CANPOLAT N., TEKINSOY B., et al.

European journal of nuclear medicine and molecular imaging , vol.38, pp.64-73, 2011 (SCI-Expanded) Sustainable Development

The association of serum adiponectin levels with histopathological variables in gastric cancer patients

ŞEKER M., Bilici A., Sönmez B., Ustaalioglu B. B., Gümüş M., Gozu H., et al.

MEDICAL ONCOLOGY , vol.27, no.4, pp.1319-1323, 2010 (SCI-Expanded) Sustainable Development

The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment.

ALIUSTAOGLU M., BILICI A., USTAALIOĞLU B., KONYA V., GUCUN M., Seker M., et al.

Medical oncology (Northwood, London, England) , vol.27, pp.1060-5, 2010 (SCI-Expanded) Sustainable Development

Neoadjuvant chemotherapy followed by interval cytoreductive surgery in patients with unresectable, advanced stage epithelial ovarian cancer: a single centre experience.

BILICI A., SALEPCI T., DANE F., GUMUS M., USTAALIOĞLU B., Seker M., et al.

Archives of gynecology and obstetrics , vol.282, pp.417-25, 2010 (SCI-Expanded) Sustainable Development

Case report: soft tissue metastasis from immature teratoma of the testis: second case report and review of the literature.

BILICI A., USTAALIOĞLU B., Seker M., KAYAHAN S.

Clinical orthopaedics and related research , vol.468, pp.2541-4, 2010 (SCI-Expanded)

Determining of metastatic lymph node ratio in patients who underwent D2 dissection for gastric cancer.

BILICI A., Seker M., USTAALIOĞLU B., YILMAZ B., DOVENTAS A., SALEPCI T., et al.

Medical oncology (Northwood, London, England) , vol.27, pp.975-84, 2010 (SCI-Expanded) Sustainable Development

Prognostic significance of perineural invasion in patients with gastric cancer who underwent curative resection.

BILICI A., Seker M., USTAALIOĞLU B., KEFELI U., YILDIRIM E. Ö., YAVUZER D., et al.

Annals of surgical oncology , vol.17, pp.2037-44, 2010 (SCI-Expanded) Sustainable Development

Clinical value of FDG PET/CT in the diagnosis of suspected recurrent ovarian cancer: is there an impact of FDG PET/CT on patient management?

BILICI A., USTAALIOĞLU B., Seker M., CANPOLAT N., TEKINSOY B., SALEPCI T., et al.

European journal of nuclear medicine and molecular imaging , vol.37, pp.1259-69, 2010 (SCI-Expanded) Sustainable Development

Malignancies diagnosed during pregnancy and treated with chemotherapy or other modalities (review of 27 cases): multicenter experiences.

Anatolian M., USTAALIOĞLU B., GUMUS M., UNAL A. S., CAYIR K., SEVER O., et al.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society , vol.20, pp.698-703, 2010 (SCI-Expanded)